戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 se of colistin has led to resistance to this cationic antimicrobial peptide.
2 are required for virulence and resistance to cationic antimicrobial peptides.
3  oxidative stress but remained vulnerable to cationic antimicrobial peptides.
4 cated as a resistance mechanism specific for cationic antimicrobial peptides.
5 idation of membrane-binding peptides such as cationic antimicrobial peptides.
6 system can sense sublethal concentrations of cationic antimicrobial peptides.
7  is required for resistance to polymyxin and cationic antimicrobial peptides.
8 is gene was designated rcp for resistance to cationic antimicrobial peptides.
9 re important for virulence and resistance to cationic antimicrobial peptides.
10 rabinose modification promotes resistance to cationic antimicrobial peptides.
11 phage phagosomes necessary for resistance to cationic antimicrobial peptides.
12 um-based peptoids similar to that for linear cationic antimicrobial peptides.
13 resistance against polymyxin antibiotics and cationic antimicrobial peptides.
14 tem responds to low extracellular Mg(++) and cationic antimicrobial peptides.
15 gainin 2 and PGLa are among the best-studied cationic antimicrobial peptides.
16 gest a functional mechanism akin to that for cationic antimicrobial peptides.
17 membrane stability and provide resistance to cationic antimicrobial peptides.
18 odel and on the organism's susceptibility to cationic antimicrobial peptides.
19 nhanced ExPortal integrity and resistance to cationic antimicrobial peptides.
20 one structure can provide protection against cationic antimicrobial peptides.
21 s, combined with an increased sensitivity to cationic antimicrobial peptides.
22 d less susceptible to focal targeting by the cationic antimicrobial peptides.
23  medium and stimulated by low pH and certain cationic antimicrobial peptides.
24  mediated by Toll-like receptor 4 (TLR4) and cationic antimicrobial peptides.
25 sium limitation, low pH, and the presence of cationic antimicrobial peptides.
26 ycerols, which is critical for resistance to cationic antimicrobial peptides.
27 ide binding and the observed specificity for cationic antimicrobial peptides.
28          PhoQ also binds and is activated by cationic antimicrobial peptides.
29 ounters in the host, including attack by the cationic antimicrobial peptides.
30 at might be important in the inactivation of cationic antimicrobial peptides.
31 saccharide, thereby lowering its affinity to cationic antimicrobial peptides.
32                                  LL-37/human cationic antimicrobial peptide 18 (hCAP18) is a human ca
33 ression promoted resistance to alpha-helical cationic antimicrobial peptides (alpha-CAMPs).
34                  Indolicidin is a 13-residue cationic, antimicrobial peptide-amide isolated from the
35 mone hepcidin was originally identified as a cationic antimicrobial peptide (AMP), but its putative e
36                                      Several cationic antimicrobial peptides (AMPs) have recently bee
37 significantly more susceptible to killing by cationic antimicrobial peptides (AMPs) of the cathelicid
38  have shown that activation of the system by cationic antimicrobial peptides (AMPs) results, among ot
39 defensins (hBDs) are epithelial cell-derived cationic antimicrobial peptides (AMPs) that also functio
40 due D-conformation amphipathic alpha-helical cationic antimicrobial peptides (AMPs), seven with "spec
41 ar survival by increasing resistance to host cationic antimicrobial peptides and decreasing host cell
42 arabinose were associated with resistance to cationic antimicrobial peptides and increased inflammato
43 uld also provide necessary binding sites for cationic antimicrobial peptides and proteins (CAMPs).
44 pathogens, providing resistance to both host cationic antimicrobial peptides and therapeutic antibiot
45  Gram-negative bacteria to resist killing by cationic antimicrobial peptides and to avoid eliciting a
46  increased resistance to aminoglycosides and cationic antimicrobial peptides, and decreased resistanc
47 mrB confers resistance of Salmonella spp. to cationic antimicrobial peptides (AP) such as polymyxin (
48                                              Cationic antimicrobial peptides (APs) are produced at mu
49                                       Linear cationic antimicrobial peptides are a diverse class of m
50                     In both of these niches, cationic antimicrobial peptides are an essential compone
51                 Human alpha-defensins, small cationic antimicrobial peptides, are found in neutrophil
52                             A group of short cationic antimicrobial peptides, called cathelicidins, h
53                                Colistin is a cationic antimicrobial peptide (CAMP) antibiotic that pe
54 ibility of the gp05 deletion mutant to human cationic antimicrobial peptide (CAMP) LL-37, neutrophils
55 nvestigated the function of ToxR and LeuO in cationic antimicrobial peptide (CAMP) resistance.
56 rulence regulators induce resistance to host cationic antimicrobial peptides (CAMP) after infection o
57                                              Cationic antimicrobial peptides (CAMP) represent a conse
58 sed endotoxicity and decreased resistance to cationic antimicrobial peptides (CAMP).
59  of acidic pH, limited divalent cations, and cationic antimicrobial peptides (CAMP).
60                                              Cationic antimicrobial peptides (CAMPs) and photodynamic
61                                              Cationic antimicrobial peptides (CAMPs) are important co
62                                              Cationic antimicrobial peptides (CAMPs) have served as t
63            To the contrary, the repulsion of cationic antimicrobial peptides (CAMPs) is attributed to
64 ith innate defenses within the host, such as cationic antimicrobial peptides (CAMPs) produced by the
65 cell envelopes against bacteriocins and host cationic antimicrobial peptides (CAMPs) produced in the
66 a common strategy used by bacteria to resist cationic antimicrobial peptides (CAMPs) secreted by othe
67 nce to complement-mediated bacteriolysis and cationic antimicrobial peptides (CAMPs), and recently we
68            Such stresses include amphipathic cationic antimicrobial peptides (CAMPs), and resistance
69                                              Cationic antimicrobial peptides (CAMPs), such as polymyx
70 s in their resistance to membrane disrupting cationic antimicrobial peptides (CAMPs), such as polymyx
71 e small peptides (<10 kDa) that included two cationic antimicrobial peptides (CAMPs), the rat catheli
72 es resistance to the bactericidal effects of cationic antimicrobial peptides (CAMPs).
73 a barrier to toxic molecules, including host cationic antimicrobial peptides (CAMPs).
74 lling by host innate immune factors, such as cationic antimicrobial peptides (CAMPs).
75 ystem contributes to bacterial resistance to cationic antimicrobial peptides (CAMPs).
76                        Natural alpha-helical cationic antimicrobial peptide (CAP) sequences are predo
77 ubstrates, the role of BrlR in resistance to cationic antimicrobial peptides (CAP), which is based on
78 al membrane, emerging research suggests that cationic antimicrobial peptides (CAPs) can influence pat
79                                              Cationic antimicrobial peptides (CAPs) occur as importan
80                                              Cationic antimicrobial peptides (CAPs) such as defensins
81 o be involved in staphylococcal responses to cationic antimicrobial peptides (CAPs).
82                  Defensins are cysteine-rich cationic antimicrobial peptides contributing to the inna
83                Hence, and in contrast to the cationic antimicrobial peptide described in the followin
84 known that the microbicidal actions of other cationic antimicrobial peptides (e.g., neutrophil defens
85               Mammalian defensins are small, cationic, antimicrobial peptides encoded by the host tha
86                           beta-Defensins are cationic antimicrobial peptides expressed in epithelia.
87      The minimum inhibitory concentration of cationic antimicrobial peptides for the two strains was
88 -3 are three members of the family of linear cationic antimicrobial peptides found in tree frogs.
89                         We set out to enrich cationic antimicrobial peptides from milk hydrolysates u
90 deficient mutant that is highly sensitive to cationic antimicrobial peptides had a normal phenotype i
91 ) limitation, acidic pH, and the presence of cationic antimicrobial peptides have been identified as
92                                      Several cationic antimicrobial peptides have been investigated a
93                            Mimics of natural cationic antimicrobial peptides have demonstrated high a
94                                              Cationic antimicrobial peptides have raised interest as
95 emokine, human beta-defensin-1 and -2, small cationic antimicrobial peptides, have also been found to
96 sistance to killing by distinct host defense cationic antimicrobial peptides (HD-CAPs).
97 almitoylation commonly confers resistance to cationic antimicrobial peptides, however, increased cyto
98  is required for resistance to polymyxin and cationic antimicrobial peptides in Escherichia coli and
99  is required for resistance to polymyxin and cationic antimicrobial peptides in Escherichia coli and
100 esses a mechanism that induces resistance to cationic antimicrobial peptides in response to environme
101 B blood and was more sensitive to killing by cationic antimicrobial peptides including moronecidin fr
102 riptional regulator and confer resistance to cationic antimicrobial peptides, including polymyxin.
103 ocidal activities demonstrated that CRAMP, a cationic antimicrobial peptide, is primarily responsible
104 Lf), and in providing protection against the cationic antimicrobial peptide lactoferricin (Lfcn).
105 gle-particle tracking reveals effects of the cationic antimicrobial peptide LL-37 on the Escherichia
106             Our results demonstrate that the cationic antimicrobial peptide LL37 converts self-RNA in
107 in the skin of psoriasis patients, the human cationic antimicrobial peptide LL37 is highly expressed
108  skin, these barriers can be breached by the cationic antimicrobial peptide LL37.
109 esign of human beta-defensin-2, a 41-residue cationic antimicrobial peptide of the innate immune syst
110           Because alpha-defensins, which are cationic antimicrobial peptides of polymorphonuclear neu
111 hanisms to resist the bactericidal action of cationic antimicrobial peptides of the innate immune sys
112   Such modification results in resistance to cationic antimicrobial peptides of the innate immune sys
113 ted in bacterial resistance to polymyxin and cationic antimicrobial peptides of the innate immune sys
114 n increased sensitivity to both colistin and cationic antimicrobial peptides of the innate immune sys
115 nst Gram-negative bacteria, the binding to a cationic antimicrobial peptide offers the attractive pro
116     When these interactions are disrupted by cationic antimicrobial peptides, or by the loss of negat
117 creased the resistance of V. fischeri to the cationic antimicrobial peptide polymixin B, which resemb
118 n strain showed increased sensitivity to the cationic antimicrobial peptide polymyxin as well as bile
119 al membrane resulting in protection from the cationic antimicrobial peptide polymyxin B.
120 ovicida mutant was highly susceptible to the cationic antimicrobial peptide polymyxin.
121 occal resistance to two structurally diverse cationic antimicrobial peptides (polymyxin B and LL-37)
122 wed a 20-fold increase in sensitivity to the cationic antimicrobial peptide, polymyxin B, as well as
123 um lipid A is required for resistance to the cationic antimicrobial peptide, polymyxin.
124 ant to human beta-defensins, which are small cationic antimicrobial peptides produced by a number of
125 y pathogenic Gram-negative bacteria to evade cationic antimicrobial peptides produced by the innate i
126 elet microbicidal protein (tPMP) is a small, cationic, antimicrobial peptide released from rabbit pla
127  Host defense peptides (HDPs), also known as cationic antimicrobial peptides, represent a diverse gro
128 vity produced two phenotypes associated with cationic antimicrobial peptide resistance and O-antigen
129                     Because of their role in cationic antimicrobial peptide resistance, we propose th
130 o separate networks of genes responsible for cationic antimicrobial peptide resistance.
131  of the bacterial surface, thereby promoting cationic antimicrobial peptide resistance.
132 ned the significance of LpxE with respect to cationic antimicrobial peptide resistance.
133       Human beta-defensins (hBDs) are small, cationic antimicrobial peptides, secreted by mucosal epi
134 ting arnT decreased resistance to killing by cationic antimicrobial peptides, such as polymyxin B and
135  to H(2)O(2) but resistant to LL-37, a human cationic antimicrobial peptide, suggests an inherent res
136 hate groups of lipid A aids in resistance to cationic antimicrobial peptides targeting the bacterial
137  fish epithelial cells and more resistant to cationic antimicrobial peptides than wild-type S. iniae.
138 Epithelial beta-defensins are broad-spectrum cationic antimicrobial peptides that also act as chemoki
139          The human beta-defensins are small, cationic antimicrobial peptides that are made by epithel
140  Human neutrophil alpha-defensins (HNPs) are cationic antimicrobial peptides that are synthesized in
141                                Defensins are cationic antimicrobial peptides that have a characterist
142                  Type A (I) lantibiotics are cationic antimicrobial peptides that have a potential us
143 1 (hBD-1) is a member of the family of small cationic antimicrobial peptides that have been identifie
144 t of this system is a diverse combination of cationic antimicrobial peptides that include the alpha-
145                      Mammalian defensins are cationic antimicrobial peptides that play a central role
146 nstitute an evolutionary conserved family of cationic antimicrobial peptides that play a key role in
147                                Defensins are cationic antimicrobial peptides that serve as important
148 ic insights into the mode-of-action of small cationic antimicrobial peptides that should facilitate i
149 ense peptides distinct from another class of cationic antimicrobial peptides, the defensins.
150 murium regulates mechanisms of resistance to cationic antimicrobial peptides through the two-componen
151 ine-rich antimicrobial peptides (PrAMPs) are cationic antimicrobial peptides unusual for their abilit
152                       Different from classic cationic antimicrobial peptides usually with high cation
153 yamines to increase gonococcal resistance to cationic antimicrobial peptides was dose dependent, corr
154 ging reasons; DeltavisP is less resistant to cationic antimicrobial peptides, whereas DeltalpxO is de
155   Piscidin belongs to a family of amphipatic cationic antimicrobial peptides, which are membrane-acti

 
Page Top